Disorders of the cardiac rhythm may occur in both the fetus and neonate. Because of the
immature myocardium, the hemodynamic consequences of either bradyarrhythmias or …

Antiarrhythmic drugs represent a mainstay of pediatric arrhythmia treatment. However,
official guidelines and consensus documents on this topic remain scarce. There are rather …

Objective: To review treatment options and updates that exist for the management of
paroxysmal supraventricular tachycardia (PSVT). Data Sources: A literature search of …

Myocardial infarction (MI) and its associated complications including ventricular arrhythmias
and heart failure are responsible for a significant incidence of morbidity and mortality …

Ivabradine is used to reduce heart rate in children with chronic heart failure and dilated
cardiomyopathy, it has recently been used off‐label to treat tachyarrhythmias such as …

Pediatric postoperative junctional ectopic tachycardia (JET), although usually self-limited,
may lead to significant morbidity and mortality. Anti-arrhythmic medications are often …

Background: Ivabradine is a novel drug with the ability to reduce heart rate without
compromising myocardial contractility or blood pressure. Studies on this drug exist mainly …

Despite the significant advances in management and prevention, heart failure still cause
high mortality and morbidity. Ivabradine is one example of a new drug used in the treatment …

Background: In 2020, it was estimated that 19 million deaths (37%) worldwide were caused
by cardiovascular diseases. Coronary Artery Disease is caused by the buildup of plaque in …

Objective: To compare the clinical outcome in terms of efficacy and safety of Ivabradine as
adjunctive therapy in patients with acute heart failure. Methods: A prospective clinical trial …